- Home
- LEE vs PMVP Comparison
LEE vs PMVP Comparison
Compare LEE & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- PMVP
- Stock Information
- Founded
- LEE 1890
- PMVP 2013
- Country
- LEE United States
- PMVP United States
- Employees
- LEE N/A
- PMVP N/A
- Industry
- LEE Newspapers/Magazines
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- LEE Consumer Discretionary
- PMVP Health Care
- Exchange
- LEE Nasdaq
- PMVP Nasdaq
- Market Cap
- LEE 39.6M
- PMVP 55.1M
- IPO Year
- LEE N/A
- PMVP 2020
- Fundamental
- Price
- LEE $6.80
- PMVP $1.25
- Analyst Decision
- LEE
- PMVP Strong Buy
- Analyst Count
- LEE 0
- PMVP 1
- Target Price
- LEE N/A
- PMVP $5.00
- AVG Volume (30 Days)
- LEE 33.9K
- PMVP 230.0K
- Earning Date
- LEE 07-31-2025
- PMVP 08-07-2025
- Dividend Yield
- LEE N/A
- PMVP N/A
- EPS Growth
- LEE N/A
- PMVP N/A
- EPS
- LEE N/A
- PMVP N/A
- Revenue
- LEE $591,094,000.00
- PMVP N/A
- Revenue This Year
- LEE N/A
- PMVP N/A
- Revenue Next Year
- LEE N/A
- PMVP N/A
- P/E Ratio
- LEE N/A
- PMVP N/A
- Revenue Growth
- LEE N/A
- PMVP N/A
- 52 Week Low
- LEE $5.83
- PMVP $0.81
- 52 Week High
- LEE $19.63
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- LEE 54.12
- PMVP 64.21
- Support Level
- LEE $6.04
- PMVP $0.96
- Resistance Level
- LEE $7.00
- PMVP $1.36
- Average True Range (ATR)
- LEE 0.37
- PMVP 0.09
- MACD
- LEE 0.08
- PMVP 0.01
- Stochastic Oscillator
- LEE 82.91
- PMVP 72.22
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.